FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Angel One IPO and Gland Pharma IPO.
Angel One IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Angel One IPO | Gland Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Edelweiss Financial Services Ltd ICICI Securities Limited SBI Capital Markets Limited |
Citigroup Global Markets India Private Limited Haitong Securities India Private Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Angel One IPO is up to ₹600.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Angel One IPO is ₹306.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.
Angel One IPO | Gland Pharma IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹305.00 per share | ₹1,490.00 per share |
Issue Price (Upper) | ₹306.00 per share | ₹1,500.00 per share |
Issue Price (Final) | ₹306.00 per share | ₹1,500.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 49 shares | 10 shares |
Fresh Issue Size | 83,33,333 shares | |
Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹1,250.00 Cr |
OFS Issue Size | 3,48,63,635 shares | |
OFS Issue Size (Amount) | up to ₹300.00 Cr | up to ₹5,229.55 Cr |
Issue Size Total | 4,31,96,968 shares | |
Issue Size Total (Amount) | up to ₹600.00 Cr | up to ₹6,479.55 Cr |
Angel One IPO opens on Sep 22, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Angel One IPO and Gland Pharma IPO is Sep 24, 2020, and Nov 11, 2020, respectively.
Angel One IPO | Gland Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Sep 22, 2020 | Nov 09, 2020 |
Issue Close | Sep 24, 2020 | Nov 11, 2020 |
Basis Of Allotment (Tentative) | Sep 29, 2020 | Nov 17, 2020 |
Initiation of Refunds (Tentative) | Sep 30, 2020 | Nov 18, 2020 |
Credit of Share (Tentative) | Oct 01, 2020 | Nov 19, 2020 |
Listing date (Tentative) | Oct 05, 2020 | Nov 20, 2020 |
Anchor Lockin End date 1 | Oct 29, 2020 | Dec 17, 2020 |
Anchor Lockin End date 2 | Dec 28, 2020 | Feb 15, 2021 |
Angel One IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .
Angel One IPO | Gland Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 65.42% | 74% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 58% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Angel One IPO retail investors (RII) are offered 68,85,246 shares while in Gland Pharma IPO retail investors are offered 68,85,246 shares. Qualified institutional buyers (QIB) are offered 39,34,425 shares in Angel One IPO and 86,39,394 shares in Gland Pharma IPO.
Angel One IPO | Gland Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 39,34,425 shares | 86,39,394 shares |
NII | 29,50,820 shares | 64,79,546 shares |
RII | 68,85,246 shares | 1,51,18,939 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,37,70,491 shares | 3,02,37,879 shares |
Angel One IPO subscribed 3.94x in total, whereas Gland Pharma IPO subscribed 2.06x.
Angel One IPO | Gland Pharma IPO | |
---|---|---|
QIB (times) | 5.74x | 6.40x |
NII (times) | 0.69x | 0.51x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 4.31x | 0.24x |
Employee (times) | ||
Other (times) | ||
Total (times) | 3.94x | 2.06x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|